Articles and resources

Universal access to NIPT: Cost-effective and precise cell-free DNA testing
Prenatal
08 Jun 2020

Universal access to NIPT: Cost-effective and precise cell-free DNA testing

This PerkinElmer satellite symposium organized at the European Society of Human Genetics (ESHG) Virtual Conference 2020 presents two laboratories’ experience with Vanadis® NIPT, an automated, non-sequencing cell-free DNA testing platform. Speakers include Dr. Alka Chaubey (PerkinElmer Global Genomic, USA) and Prof. Barbara Pasini (University of Turin, Italy).
LifeCycle™ software brochure
Prenatal
24 Apr 2020

LifeCycle™ software brochure

Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma
Prenatal
19 Aug 2019

Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma

Ericsson et al., Prenatal Diagnosis. 2019
Implementation and Validation of a High-Precision, Non-NGS NIPT Platform
Prenatal
26 Sep 2018

Implementation and Validation of a High-Precision, Non-NGS NIPT Platform

This Genomeweb webinar provides a comprehensive overview of Vanadis® NIPT system, an automated, high-precision non-invasive prenatal testing platform. Speakers: Dr. Glenn Palomaki (Women & Infants Hospital, Rhode Island, USA) and Dr Jérémie Gautier (Cerba Xpert, France).
Imaging single DNA molecules for high precision NIPT
Prenatal
14 Mar 2018

Imaging single DNA molecules for high precision NIPT

Dahl et al., Scientific Reports, 2018
The new era of cell-free DNA testing
Prenatal
15 May 2017

The new era of cell-free DNA testing

Kypros Nicolaides, Professor at King’s College Hospital, London (UK) and founder of Fetal Medicine Foundation (FMF) presents is perspective on the clinical implementation of cell-free DNA testing, in particular which chromosomal abnormalities should be screened for and the importance of the fetal fraction.
Spin gif